C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 501/48 (2006.01) A61K 31/545 (2006.01) A61K 31/695 (2006.01) C07D 213/70 (2006.01) C07D 401/04 (2006.01) C07D 501/00 (2006.01) C07F 7/10 (2006.01)
Patent
CA 2174476
Novel cephem derivatives represented by the general formula Image in which the Acyl substituent is a group of the formula Image wherein Ar is a lipophilic optionally substituted phenyl, naphthyl or pyridyl group; R1 represents either the residue of a heterocyclic amino acid or a C2-C10 alkyl group substituted by both a carboxyl group and a group of the formula -NR9R10 or Image in which R9 and R10 are each independently hydrogen or C1-C6 alkyl, said C2-C10 alkyl group being optionally interrupted by one or more nitrogen atoms or carbonyl groups, and R2 and R3 are each independently hydrogen, alkyl or aminoalkyl are gram-positive antibacterial agents, especially useful in the treatment of diseases caused by methicillin-resistant Staphylococcus aureus (also referred to below as MRSA or methicillin- resistant S. aureus).
Bronson Joanne J.
D'andrea Stanley V.
Hoeft Shelley E.
Luh Bing Yu
Matiskella John D.
Bristol-Myers Squibb Company
Gowling Lafleur Henderson Llp
LandOfFree
Cephalosporin derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cephalosporin derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cephalosporin derivatives will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1503358